水泡性口炎病毒作为疫苗载体的应用

病毒载体广泛应用于传染病疫苗研发,基于水泡性口炎病毒载体的埃博拉疫苗和多款基于腺病毒载体的新型冠状病毒疫苗已获批上市。其中水泡性口炎病毒具有易培养、安全高效、无整合风险、受人体预存免疫影响低、能刺激机体产生高强度细胞和体液免疫反应等优势,因此成为最有前景的病毒载体之一。本综述对重组水泡性口炎病毒载体的疫苗构建、应用以及面临的挑战和未来研究方向进行总结,为深入研究基于水泡性口炎病毒载体疫苗的提供了参考,也为新发突发传染病的防治提供新的策略和建议。     

水泡性口炎病毒核蛋白基因的表达及初步应用

将水泡性口炎病毒编码群特异性抗原的N基因片段克隆至pMD18-T克隆载体质粒中,构建N基因克隆重组质粒,进行核苷酸序列分析。然后亚克隆插入pBAD/Thio TOPO表达载体,经PCR限制性内切酶分析、测序鉴定,筛选获得N基因正向插入、有正确读码框的阳性克隆,成功构建了水泡性口炎病毒N基因重组表达载体。经L-Arabinose诱导表达,可稳定、高效地表达N蛋白抗原。SDS-PAGE、Western blotting及间接ELISA试验结果表明,表达蛋白为融合蛋白,质量约63.5 kD,其表达产量约占菌体总蛋白的16％,相当于92mg/L。融合蛋白中含有水泡性口炎病毒群特异性的核蛋白抗原,应用表达的VSV核蛋白抗原建立了酶联免疫吸附试验,通过对186份山羊、豚鼠实验动物人工感染VSV的血清样品和参考血清样品的检测,并与微量血清中和试验进行了比较,结果表明：以表达的VSV核蛋白为包被抗原的酶联免疫吸附试验是一种特异性强、敏感性高、快速、简单、安全的检测方法,抗原制备成本低。     

成人T细胞白血病病毒抗体的血清流行病学调查

应用间接免疫荧光试验和明胶凝集试验,对10,013份血清标本进行了人T细胞白血病病毒(HTLV-1)抗体的检测,发现8例阳性。其中3例为日本人,2例是中国台湾人,2例分别是上述日本人和台湾人的妻子,均为中国人,从未离开过大陆;另一例是成人T细胞白血病病人,原为浙江渔民,后当海员,常在日本港口居住。700例各类白血病病人和10例疑似成人T细胞白血病病人的血清,HTLV-1抗体均为阴性。此结果证实,中国大陆正常成年人HTLV-1抗体阴性。少数阳性者均与密切接触日本人有关。HTLV-1病毒是由日本人传入的。     

水泡性口炎病毒对IPEC-J2细胞因子转录时相的影响

摘要：【目的】为了更好的了解水泡性口炎病毒（VSV）感染后引起细胞炎性反应特别是炎性细胞因子的反应,探讨宿主-病毒之间的作用关系。【方法】我们运用荧光定量PCR技术,测定和分析VSV感染IPEC-J2细胞引起的病毒RNA量的变化和细胞因子IL-2、6、8、10、12、IFN-α、 IFN -γ、TNF-α、TGF-β和TLR3分泌水平。【结果】我们发现,VSV感染后引起IPEC-J2细胞分泌IL-6、8、12、TNF-α和TLR3显著增加,TGF-β无显著差异;IPEC-J2细胞不分泌IL-2、IL-10、IFN-α和IFN –γ。【结论】水泡性口炎病毒感染可引起IPEC-J2细胞炎性分子分泌增加。     

HTLV-1病毒蛋白Tax和HBZ协同促进成人T细胞白血病发生的机制

人类T细胞白血病1型病毒(Human T-cell leukemia virus type 1,HTLV-1)是与人类疾病发生密切相关的逆转录病毒。该病毒的感染可引起成人T细胞白血病(Adult T-cell leukemia,ATL)等多种疾病的发生。Tax和HBZ(HTLV-1 basic zipper protein)是由HTLV-1前病毒编码的两个关键病毒蛋白,它们被认为在HTLV-1病毒的复制、生存和致癌过程中发挥了至关重要的作用。本文就Tax和HBZ的蛋白结构以及它们在调控病毒转录、细胞生长和凋亡、病毒潜伏期,最终协同促进成人T细胞白血病发生过程中发挥的作用作一综述。     

乳杆菌DM9811发酵液提取物中RNA组分对水泡性口炎病毒抑制作用研究

目的通过乳杆菌DM9811发酵液提取物中RNA组分对水泡性口炎病毒(VSV)抑制作用研究,探讨其在抵抗肠道病毒性感染性疾病方面的作用。方法应用50%细胞感染计量法(TCID50)、免疫荧光法、ELISA和MTT法探讨不同浓度的RNA组分对VSV的抑制作用。结果 RNA组分200μg/mL浓度时与对照比较,RNA组分具有竞争性抑制VSV感染作用,细胞存活率为(90.9±3.67)%,并具有阻断VSV侵入细胞作用,细胞存活率为(96.6±1.47)%。但RNA组分对病毒生物合成的抑制作用不明显。此外RNA组分具有诱导BALB/c小鼠脾细胞产生IFN-α作用,并呈现一定的剂量依赖关系。结论乳杆菌DM9811发酵液提取物中RNA组分对VSV具有明显抑制作用。     

成人T细胞白血病

<正>前言 1979年高月等发现成人T细胞白血病(ATL),指出是以日本冲绳,南九洲,四国,纪伊和三陆,以及加勒比海沿岸各国为中心多发的淋巴瘤和白血病,据Gallo和日沼等证实病原病毒是逆转录病毒的人I型T淋巴细胞病毒(HTLV—I)。吉田等确定了病毒基因的全部碱基序列。 HTLV—I的主要传播途径,是以母乳为媒介的母子间垂直传播、经性行为的横向传播及输血,但详细的传播机制还不完全清楚。HTLV—I如进入人的淋巴细胞内,就与其他逆转录病毒一样,两条病毒RNA经自身的逆转录酶作用转化为DNA,形成双链DNA后随机插入宿主DNA中,以前病毒DNA的形式继续存在。因此,可用HTLV—IDNA诊断ATL患者的淋巴细胞DNA。     

人T细胞白血病病毒Ⅰ型的研究现状

人T细胞白血病病毒Ⅰ型 (HTLV I)是一类在人体可引起严重疾病的逆转录病毒。有数据表明国内局部地区存在小的流行 ,本文从病原学、流行病学、监床表现、实验室诊断等方面对其作一综述。     

Association of polyadenylic acid with messenger RNA of vesicular stomatitis virus

Polyadenylate (poly(A)) sequences are associated with the 28 S and 13–15 S messenger RNA species of vesicular stomatitis virus. These sequences contain approximately 125 to 150 nucleotides. Virion RNA contains little or no poly(A) sequences. The association of poly(A) with viral messenger RNA species and the gross distribution of poly(A) among these species remain unaltered even when the RNA is synthesized in the presence of cordycepin or cycloheximide and whether viral messenger RNA is polyribosome-bound or free. Also, when viral translation is completely inhibited by superinfection with poliovirus, there is no effect on poly(A) association with the messenger RNA of vesicular stomatitis virus.     

The structure of vesicular stomatitis virus membrane A phosphorus nuclear magnetic resonance approach

The proton decoupled 40.48 M Hz ³¹P NMR spectrum of intact and unperturbed membrane-enclosed vesicular stomatitis virus (serotype Indiana) exhibited two distinct maxima. These can be resolved into a narrow, symmetric line and a broad asymmetric line. The ³¹P NMR spectrum of a multilamellar (unsonicated) preparation of the extracted viral lipids exhibited a line shape similar to that of the intact virus. A sonicated vesicle preparation of the extracted viral lipids exhibited a narrow symmetric line. The narrow component in the intact virus spectrum may be attributed to small membrane fragments. Phospholipase C digestion of the intact virus resulted in substantial reduction in intensity of both components which suggests that much of the contribution to both peaks is due to phosphate in the phospholipid polar head groups.The phospholipid phosphates in both sonicated and unsonicated preparations of the extracted viral lipids exhibited substantially longer relaxation times than did those in the intact virus. The short relaxation time emanating from the intact virus preparation is caused by immobilization of the phospholipid head groups which could be due to lipid-protein interactions. Trypsin treatment of vesicular stomatitis virions, which results in complete removal of the exterior hydrophilic segment of the membrane glycoprotein, increased the ³¹P relaxation time to a value similar to that observed in the protein-free total lipid extracts; this finding provides supporting evidence for the role of virus glycoprotein in shortened relaxation times. A reversible temperature-dependent change in apparent line width and absence of an effect of cholesterol on the ³¹P phospholipid spectrum were also demonstrated.     

Assembly of the vesicular stomatitis virus envelope: incorporation of viral polypeptides into the host plasma membrane

Incorporation of viral polypeptides into the host plasma membrane is an essential step in the formation of the lipoprotein envelope of vesicular stomatitis virus. A quantitative study of this process was carried out using a double-isotope labeling procedure. Infected cells were incubated for two hours with ¹⁴C-labeled amino acids, pulse-labeled with [³H]leucine and incubated for various times with an excess of non-radioactive leucine. The ${}^3\text{H}{}^{14}\text{C}$ ratio was determined for each viral polypeptide in isolated plasma membranes and in the whole cell by polyacrylamide gel electrophoresis. It was found that [³H]leucine-labeled viral polypeptides could be detected in the plasma membranes immediately following a 30-second pulse but that the ${}^3\text{H}{}^{14}\text{C}$ ratios of polypeptides in the plasma membrane did not reach the ${}^3\text{H}{}^{14}\text{C}$ ratios in the whole cells until the end of a two-minute chase period. The addition of puromycin to the cultures at the end of the pulse period did not affect subsequent incorporation of [³H]leucine-labeled polypeptides into the plasma membrane. The incorporation of various amino acid analogs into the viral polypeptides did not affect the efficiency with which they were incorporated into the plasma membranes. It is proposed that viral polypeptides are selected for incorporation into the plasma membrane from a small interior pool of completed molecules.     

Permeability properties of the membrane of vesicular stomatitis virions

Observations of the light-scattering properties of several enveloped viruses indicate that virions (vesicular stomatitis, SV5 and influenza), in common with other membrane systems, are osmotically active, responding to NaCl gradients by swelling in hypo-osmolar solutions and shrinking in hyperosmolar solutions. The permeability barrier responsible for this osmotic response in vesicular stomatitis virions was modified both by protease treatment to remove the viral glycoprotein and by treatment with the polyene antibiotic filipin, an agent known to interact with cholesterol in liposomes and membranes. Filipin altered the kinetic and equilibrium permeability behavior of virions but the extent of leakage of osmotic shocking agent was less than that in lecithin/cholesterol and lecithin/ergosterol liposomes and in ergosterol-containing ciliary membranes. Negative-staining electron microscopy revealed that filipin treatment caused structural changes in the viral membrane. Intact virions exhibited appreciably larger responses to osmotic change than did protease-treated virus particles. Thus, the osmotic barrier in intact vesicular stomatitis virions may not be exclusively lipid in nature.     

Asymmetric distribution of phosphatidylethanolamine fatty acyl chains in the membrane of vesicular stomatitis virus

The membrane of vesicular stomatitis virus (VSV) contains two distinct pools of phosphatidylethanolamine molecules which reside in the inner and outer phospholipid monolayers, respectively. 36% of the total membrane phosphatidylethanolamine is found in the outer monolayer while 64% is found in the inner. The two pools of VSV phosphatidylethanolamine can be distinguished operationally by the fact that only outer phosphatidylethanolamine is reactive in intact virions with the membrane-impermeable reagent trinitrobenzenesulfonate (TNBS). We have made use of this property to separate inner from outer VSV phosphatidylethanolamine and to determine the fatty acyl chain compositions of the two phosphatidylethanolamine pools separately. The results show that compared to outer phosphatidylethanolamine, inner phosphatidylethanolamine molecules contain a significantly higher proportion of unsaturated fatty acyl chains. Furthermore, whereas the proportion of unsaturated fatty acyl chains was found to be quite similar at the 1 and 2 glycerol carbon atoms in inner phosphatidylethanolamine, a marked dissimilarity was observed in outer phosphatidylethanolamine; outer phosphatidylethanolamine was enriched in saturated fatty acyl chains at the 1 position and in unsaturated fatty acyl chains at the 2 position. The differential fatty acyl chain composition of inner compared to outer phosphatidylethanolamine indicates that rapid, random transmembrane migration (flip-flop) of phosphatidylethanolamine does not occur in the VSV membrane. The nature of the fatty acyl chain asymmetry observed in VSV phosphatidylethanolamine does not support the view that the     

Expression of the vesicular stomatitis virus nucleocapsid protein controlled by the lambda PR and PL promoters in Escherichia coli

Expression vectors were constructed in which a cDNA specifying the vesicular stomatitis virus nucleocapsid (VSV N) protein was inserted near the translational initiation region downstream from the thermoinducible P_R or P_L promoter of bacteriophage λ. Expression of the VSV N-protein was determined by a radioimmunoassay with monoclonal antibody prepared against the VSV N-protein. The expression of the VSV N-protein in Escherichia coli was low with either system. However, the deletion of a part of leader sequence from the translational initiation signal to the VSV N-gene resulted in at least 30-fold increase in production of the VSV N-protein. The VSV N-protein in E. coli was also analyzed by radioimmune blot after separation of proteins by gel electrophoresis. Degraded proteins reacted with the antibody were also observed in the cell extracts.     

Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells

The vesicular stomatitis virus (VSV) glycoprotein (G) was used to prepare virosomes as a model vehicle of gene transfer to animal cells, for which viral envelope functions (receptor recognition and binding and the pH-dependent membrane-fusion) were expected to work. Plasmid DNA (pEGFP-N1; Clontech) was first encapsulated into liposomes by a method of repeated freezing and thawing of the mixture of DNA and lipids (phosphatidylcholine, phosphatidylserine and cholesterol mixed at a molar ratio of 5: 1: 4). Then, particle size of the liposomes was stepwise reduced to 200 nm or less in diameter by successive filtrations through a series of plastic filters of various pore sizes (10 micro m, 2 micro m, 0.65 micro m, and then 0.45 micro m). Assembly of the VSV G protein-coated liposomes (VSV G-virosomes) was performed by mixing the DNA-encapsulated liposome suspensions with the purified VSV G proteins at pH 5.5, followed by ultracentrifugation in a discontinuous sucrose gradient. The highest gene-transducing activity was detected in a single band formed between 20% and 45% sucrose layers. Negatively stained electron microscopic images showed that the band contained spherical particles of various sizes, ranging from 40 to 140 nm in diameter, that were covered with viral spike projections. The VSV G-virosomes displayed a roughly similar level of gene-transducing activity to that mediated by cationic liposomes (e.g., Lipofectamine), which was blocked either by pretreatment with anti-VSV G antiserum or by addition of 20 m M NH(4) Cl to transfected cultures. From these results, we assume that the virosome-mediated gene-transduction was first achieved by using the whole functions of VSV G protein, and can also be used for further studies of the protein.     

Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity

A quantitative understanding of the innate immune response will enable its recruitment against emerging, poorly characterized, or weaponized viral pathogens. To gain insights into how the innate responses can limit viral spread, we used quantitative focal infections to study how the spread of recombinant vesicular stomatitis viruses (VSV) on baby hamster kidney (BHK) and delayed brain tumor (DBT) cell monolayers is affected by innate cellular antiviral responses. We observed that rates of infection spread correlated with one-step growth rankings for four ectopic VSV strains: N1, N2, N3, and N4. However, this correlation was lost for M51R, a recombinant VSV mutant that lacks the ability to shut-off host gene expression. In BHK cells, M51R spread at two-thirds the rate of the recombinant control virus, XK3.1, even though their one-step growth was comparable. In DBT cells, M51R infections failed to spread beyond the site of inoculation. Addition of anti-interferon antibody restored M51R spread and one-step growth to wild-type levels. Interestingly, the antibody enhanced the spread of wild-type virus but not its growth. These results suggest that while the rate of viral spread generally correlates with the rate of viral growth, the induction of cellular antiviral activities can be in some cases, the overriding factor in both spread and growth. In summary, focal infections enabled us to visualize and quantify how viral spread was inhibited by cellular antiviral activities. This study demonstrates a mechanism for quantifying how innate cellular responses can mitigate infection spread in vitro.